Sanguisorba officinalis L. Suppresses Triple-Negative Breast Cancer Metastasis by Inhibiting Late-Phase Autophagy via Hif-1α/Caveolin-1 Signaling
Sanguisorba officinalis L. (SA) is a common herb for cancer treatment in the clinic, particularly during the consolidation phase to prevent occurrence or metastasis. Nevertheless, there are limited studies reporting the molecular mechanisms about its anti-metastatic function. It is well demonstrated...
Main Authors: | Neng Wang, Gulizeba Muhetaer, Xiaotong Zhang, Bowen Yang, Caiwei Wang, Yu Zhang, Xuan Wang, Juping Zhang, Shengqi Wang, Yifeng Zheng, Fengxue Zhang, Zhiyu Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.591400/full |
Similar Items
-
ANTIOXIDANT CAPACITY OF SANGUISORBA OFFICINALIS L. AND SANGUISORBA MINOR SCOP
by: Tocai (Moţoc) Alexandra Cristina, et al.
Published: (2021-05-01) -
A Comprehensive Review of Genus Sanguisorba: Traditional Uses, Chemical Constituents and Medical Applications
by: Ping Zhou, et al.
Published: (2021-09-01) -
Ursolic Acid Inhibits Breast Cancer Metastasis by Suppressing Glycolytic Metabolism via Activating SP1/Caveolin-1 Signaling
by: Shengqi Wang, et al.
Published: (2021-09-01) -
Determination of Triterpenoids and Phenolic Acids from <i>Sanguisorba officinalis</i> L. by HPLC-ELSD and Its Application
by: Jiahui Sun, et al.
Published: (2021-07-01) -
Elucidation of the molecular mechanism of Sanguisorba Officinalis L. against leukopenia based on network pharmacology
by: Long Wang, et al.
Published: (2020-12-01)